ATRHealthcare · Medical Instruments & SuppliesThe 9 Wall Street analysts covering AptarGroup, Inc. hold a median 12-month price target of $156 — +22.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 47 of 100 as at 26 Oct 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores AptarGroup, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (92): The share price has been relatively steady.
Value (25): The shares cost a lot relative to the profits and assets behind them.
Size (17): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on ATR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +22.9% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Oct 2026 | UBS | Initiates | Neutral | $135 |
| 3 Aug 2026 | Wells Fargo | Maintains | Overweight | $145 → $155 |
| 3 Aug 2026 | Wells Fargo | Maintains | Overweight | — |
| 4 May 2026 | Wells Fargo | Maintains | Overweight | — |
| 4 May 2026 | Wells Fargo | Maintains | Overweight | $144 → $145 |
| 20 Mar 2026 | Wells Fargo | Upgrade | Overweight | — |
| 6 Jan 2026 | Wells Fargo | Downgrade | Equal-Weight | — |
| 3 Nov 2025 | Baird | Maintains | Outperform | — |
| 3 Nov 2025 | Wells Fargo | Maintains | Overweight | — |
| 10 Sept 2025 | Wells Fargo | Maintains | Overweight | — |
| 4 Sept 2025 | Keybanc | Initiates | Overweight | — |
| 4 Aug 2025 | Raymond James | Maintains | Outperform | — |
| 4 Aug 2025 | Wells Fargo | Maintains | Overweight | — |
| 18 July 2025 | Wells Fargo | Maintains | Overweight | — |
| 15 July 2025 | Raymond James | Maintains | Outperform | — |
| 6 May 2025 | Wells Fargo | Maintains | Overweight | — |
| 22 Apr 2025 | Raymond James | Maintains | Outperform | — |
| 10 Feb 2025 | Baird | Maintains | Outperform | — |
| 10 Feb 2025 | Raymond James | Reiterates | Outperform | — |
| 10 Feb 2025 | Wells Fargo | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
ATR appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 27 Oct 2026, AptarGroup, Inc. returned −0.6% against +13.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 33% of US stocks
Cheaper than 51% of US stocks
Cheaper than 30% of US stocks
Cheaper than 32% of US stocks
Higher than 43% of US stocks
Higher than 20% of US stocks
Higher than 43% of US stocks
Higher than 68% of US stocks
Higher than 68% of US stocks
Higher than 71% of US stocks
Higher than 82% of US stocks
Higher than 75% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
AptarGroup, Inc. has a market value of $8.1B and an enterprise value of $9.3B.
Revenue in the twelve months to 31 Mar 2026: $3.9B. The latest quarter grew 6.3% year on year.
Net income over the same four quarters: $386.6M, a 10.0% net margin.
Diluted earnings per share, trailing twelve months: $5.84.
Free cash flow in the twelve months to 31 Mar 2026: $323.9M, after $279.0M of capital spending.
AptarGroup, Inc. spent $385.0M on share buybacks and $121.8M on dividends in the twelve months to 31 Mar 2026.
Trailing P/E: 22.9×; forward P/E: 20.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.51%, paying out 34% of earnings.
AptarGroup, Inc. employs 14,000 people — $277K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own AptarGroup, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
AptarGroup’s Q3 earnings are expected to decline, and the excerpt says the company lacks the combination of two key ingredients associated with a likely earnings beat. The source points readers to key expectations ahead of the report.
Why it matters — ATR watchers may note the negative earnings outlook as they follow the upcoming Q3 report.
AptarGroup's stock is technically in oversold territory after a 5.9% decline over four weeks, which may signal that heavy selling pressure has been exhausted. Wall Street analysts show strong agreement in raising earnings estimates, which could lead to a trend reversal for the stock.
Why it matters — AptarGroup watchers would care because oversold conditions combined with upward analyst estimate revisions may signal a potential reversal in the stock's recent downward trend.
Zacks reported that while weak demand and tariffs cloud the near-term outlook for the Containers - Paper and Packaging industry, AptarGroup (ATR) is among three packaging stocks navigating the challenges well.
Why it matters — For ATR watchers, this indicates the company is regarded as relatively well-positioned despite broader industry headwinds.
AptarGroup, Inc. presented at the Morgan Stanley 24th Annual Global Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The presentation was part of the company's participation in the industry event.
Why it matters — ATR watchers would want to review the transcript for management's remarks on the company's healthcare segment and strategy presented to investors at this major conference.
AptarGroup, Inc. presented at the Wells Fargo 21st Annual Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The presentation covered the company's healthcare segment activities at the investor event.
Why it matters — ATR watchers would care because the presentation offers direct insight into the company's healthcare business and its messaging to investors at a major industry conference.
The 9 Wall Street analysts covering AptarGroup, Inc. have a median 12-month price target of $156, with estimates ranging from $135 to $220. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering AptarGroup, Inc., 7 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks AptarGroup, Inc. 47 out of 100 across roughly 4,600 US stocks as at 26 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 26 Oct 2026, AptarGroup, Inc. ranks 47 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (92 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +22.9% from the last close, and Ticker Nerd's factor model ranks AptarGroup, Inc. 47 out of 100 as at 26 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering AptarGroup, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ATR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $135 to $220 over the next 12 months.
AptarGroup, Inc. returned -0.6% over the 12 months to 27 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
AptarGroup Inc. is a global packaging and dispensing technology company that designs and manufactures drug delivery systems, consumer product dispensers, sealing solutions, and active packaging.
The most recent item we track (Zacks Investment Research, 22 Oct 2026): "Earnings Preview: AptarGroup (ATR) Q3 Earnings Expected to Decline". AptarGroup’s Q3 earnings are expected to decline, and the excerpt says the company lacks the combination of two key ingredients associated with a likely earnings beat. The source points readers to key expectations ahead of the report.
AptarGroup Inc. is a global packaging and dispensing technology company that designs and manufactures drug delivery systems, consumer product dispensers, sealing solutions, and active packaging. AptarGroup Inc. serves pharmaceutical, consumer health, beauty, personal care, home care, food, and beverage markets with products such as pumps, valves, closures, nasal spray systems, inhalers, and elastomeric components used in injectable and other drug packaging applications. The company also provides active material science and digital health solutions that support product protection, dosing, and delivery performance across healthcare and consumer applications. AptarGroup Inc. operates through focused business segments including Pharma, Beauty, and Closures, positioning it as a key supplier to brands that rely on precise dispensing, protective packaging, and differentiated user experience in highly regulated and consumer-facing markets.
CEO Mr. Gael Touya · 14,000 employees · United States · https://www.aptar.com
